APOA5 Gene Polymorphisms and Cardiovascular Diseases: Metaprediction in Global Populations

Yen Chun Lin, Veronica Nunez, Robin F Johns, Shyang-Yun Pamela Shiao

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background Apolipoprotein A5 (APOA5) 1131 is one of the most investigated gene polymorphisms in association with cardiovascular diseases (CVD) for its roles in epigenetics pathways. Objectives The major objective of this metaprediction study was to comprehensively examine the association of polymorphism risk subtypes of APOA5 1131 gene and potential contributing factors of CVD risks in global populations. Methods This study is a meta-analysis to determine APOA5 gene polymorphisms as risk factors for CVDs. Following the guidelines of meta-analyses, we applied big data analytics including the recursive partition tree, nonlinear association curve fit, and heat maps for data visualization - in addition to the conventional pooled analyses. Results A total of 17,692 CVD cases and 23,566 controls from 50 study groups were included. The frequency of APOA5 1131 CC and TC polymorphisms in Asian populations (22.2%-52.6%) were higher than that in other populations, including Caucasians and Eurasians (10.0%-25.0%). The homozygous CC and heterozygous TC genotypes (both p <.0001) were associated with increased risks for CVD and were higher in many Western nations, including Canada, Spain, the Czech Republic, Hungary, Turkey, Egypt, France, and Iran. The CC genotype was associated with greater risks (RR > 2.00, p <.0001) for dyslipidemia and myocardial infarction, whereas RR > 1.00 was associated with metabolic syndrome, coronary artery disease, and stroke. Air pollution was significantly associated with APOA5 1131 CC and TC polymorphisms. Discussion The findings of this study provided novel insight to further understand the associations among APOA5 1131 polymorphisms, air pollution, and the development of CVDs. Methylation studies are needed to examine epigenetic factors associated with APOA5 1131 polymorphisms and CVD and to suggest potential prevention strategies for CVD.

Original languageEnglish (US)
Pages (from-to)164-174
Number of pages11
JournalNursing Research
Volume66
Issue number2
DOIs
StatePublished - Mar 1 2017

Fingerprint

Cardiovascular Diseases
Population
Genes
Air Pollution
Epigenomics
Meta-Analysis
Apolipoproteins
Methylation
Apolipoprotein A-V
Coronary Artery Disease
Hot Temperature
Stroke
Genotype
Guidelines

Keywords

  • apolipoprotein A5
  • cardiovascular disease
  • metaprediction

ASJC Scopus subject areas

  • Nursing(all)

Cite this

APOA5 Gene Polymorphisms and Cardiovascular Diseases : Metaprediction in Global Populations. / Lin, Yen Chun; Nunez, Veronica; Johns, Robin F; Shiao, Shyang-Yun Pamela.

In: Nursing Research, Vol. 66, No. 2, 01.03.2017, p. 164-174.

Research output: Contribution to journalArticle

Lin, Yen Chun ; Nunez, Veronica ; Johns, Robin F ; Shiao, Shyang-Yun Pamela. / APOA5 Gene Polymorphisms and Cardiovascular Diseases : Metaprediction in Global Populations. In: Nursing Research. 2017 ; Vol. 66, No. 2. pp. 164-174.
@article{c8b8202dc51742028b123f7b3bf3c9f2,
title = "APOA5 Gene Polymorphisms and Cardiovascular Diseases: Metaprediction in Global Populations",
abstract = "Background Apolipoprotein A5 (APOA5) 1131 is one of the most investigated gene polymorphisms in association with cardiovascular diseases (CVD) for its roles in epigenetics pathways. Objectives The major objective of this metaprediction study was to comprehensively examine the association of polymorphism risk subtypes of APOA5 1131 gene and potential contributing factors of CVD risks in global populations. Methods This study is a meta-analysis to determine APOA5 gene polymorphisms as risk factors for CVDs. Following the guidelines of meta-analyses, we applied big data analytics including the recursive partition tree, nonlinear association curve fit, and heat maps for data visualization - in addition to the conventional pooled analyses. Results A total of 17,692 CVD cases and 23,566 controls from 50 study groups were included. The frequency of APOA5 1131 CC and TC polymorphisms in Asian populations (22.2{\%}-52.6{\%}) were higher than that in other populations, including Caucasians and Eurasians (10.0{\%}-25.0{\%}). The homozygous CC and heterozygous TC genotypes (both p <.0001) were associated with increased risks for CVD and were higher in many Western nations, including Canada, Spain, the Czech Republic, Hungary, Turkey, Egypt, France, and Iran. The CC genotype was associated with greater risks (RR > 2.00, p <.0001) for dyslipidemia and myocardial infarction, whereas RR > 1.00 was associated with metabolic syndrome, coronary artery disease, and stroke. Air pollution was significantly associated with APOA5 1131 CC and TC polymorphisms. Discussion The findings of this study provided novel insight to further understand the associations among APOA5 1131 polymorphisms, air pollution, and the development of CVDs. Methylation studies are needed to examine epigenetic factors associated with APOA5 1131 polymorphisms and CVD and to suggest potential prevention strategies for CVD.",
keywords = "apolipoprotein A5, cardiovascular disease, metaprediction",
author = "Lin, {Yen Chun} and Veronica Nunez and Johns, {Robin F} and Shiao, {Shyang-Yun Pamela}",
year = "2017",
month = "3",
day = "1",
doi = "10.1097/NNR.0000000000000207",
language = "English (US)",
volume = "66",
pages = "164--174",
journal = "Nursing Research",
issn = "0029-6562",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - APOA5 Gene Polymorphisms and Cardiovascular Diseases

T2 - Metaprediction in Global Populations

AU - Lin, Yen Chun

AU - Nunez, Veronica

AU - Johns, Robin F

AU - Shiao, Shyang-Yun Pamela

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Background Apolipoprotein A5 (APOA5) 1131 is one of the most investigated gene polymorphisms in association with cardiovascular diseases (CVD) for its roles in epigenetics pathways. Objectives The major objective of this metaprediction study was to comprehensively examine the association of polymorphism risk subtypes of APOA5 1131 gene and potential contributing factors of CVD risks in global populations. Methods This study is a meta-analysis to determine APOA5 gene polymorphisms as risk factors for CVDs. Following the guidelines of meta-analyses, we applied big data analytics including the recursive partition tree, nonlinear association curve fit, and heat maps for data visualization - in addition to the conventional pooled analyses. Results A total of 17,692 CVD cases and 23,566 controls from 50 study groups were included. The frequency of APOA5 1131 CC and TC polymorphisms in Asian populations (22.2%-52.6%) were higher than that in other populations, including Caucasians and Eurasians (10.0%-25.0%). The homozygous CC and heterozygous TC genotypes (both p <.0001) were associated with increased risks for CVD and were higher in many Western nations, including Canada, Spain, the Czech Republic, Hungary, Turkey, Egypt, France, and Iran. The CC genotype was associated with greater risks (RR > 2.00, p <.0001) for dyslipidemia and myocardial infarction, whereas RR > 1.00 was associated with metabolic syndrome, coronary artery disease, and stroke. Air pollution was significantly associated with APOA5 1131 CC and TC polymorphisms. Discussion The findings of this study provided novel insight to further understand the associations among APOA5 1131 polymorphisms, air pollution, and the development of CVDs. Methylation studies are needed to examine epigenetic factors associated with APOA5 1131 polymorphisms and CVD and to suggest potential prevention strategies for CVD.

AB - Background Apolipoprotein A5 (APOA5) 1131 is one of the most investigated gene polymorphisms in association with cardiovascular diseases (CVD) for its roles in epigenetics pathways. Objectives The major objective of this metaprediction study was to comprehensively examine the association of polymorphism risk subtypes of APOA5 1131 gene and potential contributing factors of CVD risks in global populations. Methods This study is a meta-analysis to determine APOA5 gene polymorphisms as risk factors for CVDs. Following the guidelines of meta-analyses, we applied big data analytics including the recursive partition tree, nonlinear association curve fit, and heat maps for data visualization - in addition to the conventional pooled analyses. Results A total of 17,692 CVD cases and 23,566 controls from 50 study groups were included. The frequency of APOA5 1131 CC and TC polymorphisms in Asian populations (22.2%-52.6%) were higher than that in other populations, including Caucasians and Eurasians (10.0%-25.0%). The homozygous CC and heterozygous TC genotypes (both p <.0001) were associated with increased risks for CVD and were higher in many Western nations, including Canada, Spain, the Czech Republic, Hungary, Turkey, Egypt, France, and Iran. The CC genotype was associated with greater risks (RR > 2.00, p <.0001) for dyslipidemia and myocardial infarction, whereas RR > 1.00 was associated with metabolic syndrome, coronary artery disease, and stroke. Air pollution was significantly associated with APOA5 1131 CC and TC polymorphisms. Discussion The findings of this study provided novel insight to further understand the associations among APOA5 1131 polymorphisms, air pollution, and the development of CVDs. Methylation studies are needed to examine epigenetic factors associated with APOA5 1131 polymorphisms and CVD and to suggest potential prevention strategies for CVD.

KW - apolipoprotein A5

KW - cardiovascular disease

KW - metaprediction

UR - http://www.scopus.com/inward/record.url?scp=85016175327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016175327&partnerID=8YFLogxK

U2 - 10.1097/NNR.0000000000000207

DO - 10.1097/NNR.0000000000000207

M3 - Article

C2 - 28252576

AN - SCOPUS:85016175327

VL - 66

SP - 164

EP - 174

JO - Nursing Research

JF - Nursing Research

SN - 0029-6562

IS - 2

ER -